Tag: VERVE-102
Gene Editing Trial Achieves 84% Cholesterol Reduction Using Single Injection
A groundbreaking clinical trial shows that a single injection of gene editing therapy VERVE-102 can reduce LDL cholesterol by up…
Submit Your Paper to GMJ
No APC until January 2027.